PROF — Profound Medical Corp.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1628808 ·
Last close
$6.80
Market Cap
$248.42M
52W High
$8.50
52W Low
$6.30
ADV30
116,599
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 2,483,000 | 1,947,000 | -11,066,000 | -9,540,000 | 62,385,000 | 38,271,000 | 12,577,000 |
| Mar 2026 | 5,337,000 | 3,832,000 | -8,021,000 | -7,053,000 | 73,456,000 | 50,295,000 | 14,032,000 |
| Dec 2025 | 5,977,000 | 3,991,000 | -7,369,000 | -8,175,000 | 77,475,000 | 59,723,000 | 11,041,000 |
| Sep 2025 | 5,289,000 | 3,931,000 | -8,913,000 | -7,977,000 | 42,305,000 | 24,826,000 | 10,162,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-38,507,000
Investing CF
—
Financing CF
$41,428,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.24
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-294,793,000
Inventory
$9,001,000
Receivables
$9,423,000
ST Investments
—
EBIT TTM
$-38,109,000
Pretax Income TTM
$-38,664,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,086,000
EBITDA
$-34,878,000
Free Cash Flow
$-24,819,624
Enterprise Value
$217,165,312
Total Cash
$38,271,000
Total Debt
$7,380,000
Shares Out
36,532,594
Trailing EPS
$-0.99
Book Value
$1.36
ROE
-73.5%
ROA
-39.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,098,000 | -41,254,000 | -42,570,000 | 77,475,000 | 11,041,000 | — | -38,207,000 |
| Dec 2024 | 10,680,000 | -33,062,000 | -27,816,000 | 70,234,000 | 9,812,000 | — | -23,453,000 |
| Dec 2023 | 7,199,000 | -28,651,000 | -28,323,000 | 43,956,000 | 12,732,000 | — | -22,609,000 |
| Dec 2022 | 6,681,000 | -29,602,000 | -28,669,000 | 64,421,000 | 12,417,000 | — | -25,800,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.59
Max Pain — expiry 2026-10-16
max pain strike: $7.50 · spot: $6.80 · call oi: 781 · put oi: 1,317
Expected Move to 2026-10-16:
±$1.34
(19.71%) —
implied range
$5.46 –
$8.14
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INFU | InfuSystem Holdings, Inc | $241.17M | $11.95 | — |
| OSUR | ORASURE TECHNOLOGIES INC | $263.46M | $3.82 | — |
| UTMD | UTAH MEDICAL PRODUCTS INC | $228.03M | $71.62 | — |
| ZJYL | Jin Medical International Ltd. | $223.94M | $3.04 | — |
| STIM | Neuronetics, Inc. | $220.21M | $2.89 | — |
News headlines (Yahoo Finance, 1h cache)
Profound Medical Announces Management Change
2026-08-14 20:30 · Yahoo
Profound Medical (PROF) Q2 2026 Earnings Call Transcript
2026-08-13 23:44 · Yahoo
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
2026-08-13 20:15 · Yahoo
Profound Medical (PROF) Q2 Earnings Surpass Estimates
2026-08-07 02:35 · Yahoo
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
2026-08-17 12:30 · Yahoo
Profound Medical Corp. Q2 2026 Earnings Call Summary
2026-08-07 12:30 · Yahoo
Profound Medical Q2 Earnings Call Highlights
2026-08-07 09:04 · Yahoo
Profound Medical Corp (PROF) (Q2 2026) Earnings Call Highlights: Record Orders and ...
2026-08-07 05:09 · Yahoo
Profound Medical Reports Second Quarter 2026 Financial Results
2026-08-06 20:12 · Yahoo
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
2026-07-24 14:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.